Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SBC | EFX |
|---|---|---|
| Price | $5.34 | $142.43 |
| Change today | ▲ 0.19% | ▼ 0.04% |
| Market cap | $549.20M | $16.73B |
| Return, 3 months | +79.2% | -14.3% |
| Return, year to date | +23.9% | -33.8% |
| Return, 1 year | +26.8% | -39.9% |
| P/E (TTM) | 11.1 | 25.0 |
| P/B | 2.1 | 3.8 |
| P/E percentile vs own 5y | 86th | 2nd |
| Dividend yield | – | 1.49% |
| Revenue growth (YoY, latest qtr) | +13.4% | +10.6% |
| Net profit growth (YoY) | +357.5% | -3.9% |
| Gross margin | 71.9% | 55.5% |
| Operating margin | 37.3% | 17.9% |
| Net margin | 28.0% | 10.7% |
| Return on equity | 19.3% | 14.6% |
| Analyst target vs. price | +59.2% | +47.2% |
| Analyst buy share | 100% | 75% |
| RSI (14) | 70 | 29 |
| 30-day volatility | 48.5% | 32.6% |
| Max drawdown, 1 year | -41.7% | -45.9% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
